Article Type
Changed
Mon, 04/16/2018 - 14:13
Display Headline
Weighing clozapine’s risks

Thank you for publishing “Clozapine for schizophrenia: Life-threatening or life-saving treatment?” (Current Psychiatry, December 2009). In recent years, prescription rates for clozapine and long-acting injectables have been low, which is a disservice to our patients. We have seen the amazing impact clozapine can have on our patients’ lives compared with other antipsychotics, and it is a shame to not prescribe it because of red tape. I am amazed that patients will stay on a medication that has so many untoward side effects, as we saw in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study. I think this is a testament to how effective the medication is.

Corey Yilmaz, MD
Southwest Behavioral Health Services
Tolleson, AZ

Article PDF
Author and Disclosure Information

Issue
Current Psychiatry - 09(03)
Publications
Topics
Page Number
5-5
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Thank you for publishing “Clozapine for schizophrenia: Life-threatening or life-saving treatment?” (Current Psychiatry, December 2009). In recent years, prescription rates for clozapine and long-acting injectables have been low, which is a disservice to our patients. We have seen the amazing impact clozapine can have on our patients’ lives compared with other antipsychotics, and it is a shame to not prescribe it because of red tape. I am amazed that patients will stay on a medication that has so many untoward side effects, as we saw in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study. I think this is a testament to how effective the medication is.

Corey Yilmaz, MD
Southwest Behavioral Health Services
Tolleson, AZ

Thank you for publishing “Clozapine for schizophrenia: Life-threatening or life-saving treatment?” (Current Psychiatry, December 2009). In recent years, prescription rates for clozapine and long-acting injectables have been low, which is a disservice to our patients. We have seen the amazing impact clozapine can have on our patients’ lives compared with other antipsychotics, and it is a shame to not prescribe it because of red tape. I am amazed that patients will stay on a medication that has so many untoward side effects, as we saw in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study. I think this is a testament to how effective the medication is.

Corey Yilmaz, MD
Southwest Behavioral Health Services
Tolleson, AZ

Issue
Current Psychiatry - 09(03)
Issue
Current Psychiatry - 09(03)
Page Number
5-5
Page Number
5-5
Publications
Publications
Topics
Article Type
Display Headline
Weighing clozapine’s risks
Display Headline
Weighing clozapine’s risks
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media